Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1000275 TORONTO, A6
Back to ANIP Full portfolio

Position in ANIP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,565,251
+$1,114,882 QoQ
Shares Held
212,192
-0.8% QoQ
Ownership
0.924%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 305 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. ANIP ranks #9 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
 9,213,269 $133,500,266
2 ZTS
Zoetis Inc.
 1,828,326 $131,383,499
3 NBIX
Neurocrine Biosciences Inc
 583,476 $98,339,041
4 BHC
Bausch Health Companies Inc.
 10,832,582 $53,404,627
5 VTRS
Viatris Inc
 3,135,460 $49,791,098
6 UTHR
UNITED THERAPEUTICS Corp
 62,600 $33,918,552
7 TEVA
Teva Pharmaceutical Industries Ltd
 953,413 $32,301,629
8 HLN
Haleon plc
 3,385,489 $31,586,609

All Filings in ANIP

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,565,251 212,192
2026-03-31 $16,450,369 213,919
2025-12-31 $17,469,261 221,298
2025-09-30 $19,300,484 210,704
2025-06-30 $13,838,415 212,083
2025-03-31 $14,085,609 210,390
2024-12-31 $11,623,504 210,266
2024-09-30 $12,557,652 210,487
2024-06-30 $304,262 4,778
2024-03-31 $335,763 4,857
2023-12-31 $249,231 4,520
2023-09-30 $163,670 2,819
2023-06-30 $94,147 1,749
2023-03-31 $35,946 905
2022-12-31 $84,401 2,098
2022-09-30 $11,119 346
2022-06-30 $7,802 263
2022-03-31 $24,286 864
2021-12-31 $99,716 2,164
2021-09-30 $35,182 1,072
2021-06-30 $30,212 862
2021-03-31 $20,310 562
2020-12-31 $110,845 3,817
2020-09-30 $107,846 3,823
2020-06-30 $121,436 3,755
2020-03-31 $151,797 3,726